INO:Inovio Pharmaceuticals Inc. - Stock Price Quote and Dividend Data
LATEST CLOSE STOCK PRICE
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years
Dividend Payment TypeReverse Split
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend Paid1970
52-Week Low/High Stock Price$1.91 - $5.95
Percent Held by Institutions51.34%
PE Ratio to Industry95%
Debt-Equity to Industry1.89%
Total Return Last 12 Months14.05%
Total Return Last 3 Years-39.37%
Total Return Last 5 Years-39.63%
Latest Trade DateFeb. 18, 2020
No Data available for Payment History.
Inovio Pharmaceuticals is a late-stage biotechnology company focused on the discovery, development and commercialization of deoxyribonucleic acid-based immunotherapies and vaccines. With Co.'s main platform technologies, Co. has developed a pipeline of clinical-stage product candidates that have generated in vivo immune responses, in particular CD8+ T cells that are fundamental in eliminating cancerous or infected cells. Co.'s primary immunotherapy product candidate is VGX-3100. Co.'s SynCon® immunotherapies are designed to treat an existing disease (therapeutic) or prevent a disease (prophylactic) by activating and magnifying an immune response to one or more disease-specific antigens.
SegmentHealth Care Equipment
IndustryMedical Instruments & Equipment
Dividend AllStar™ Ranking
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Feb. 14, 2020CLOSE PRICE INCREASE: Inovio Pharmaceuticals Inc. (NASDAQ: INO) on 02-14-2020 increased close price > 10% from $3.34 to $3.86Read more...
Feb. 04, 2020CLOSE PRICE DECREASE: Inovio Pharmaceuticals Inc. (NASDAQ: INO) on 02-04-2020 decreased close price > 10% from $4.53 to $3.91Read more...
Jan. 31, 2020CLOSE PRICE INCREASE: Inovio Pharmaceuticals Inc. (NASDAQ: INO) on 01-31-2020 increased close price > 10% from $4.11 to $4.66Read more...
Feb. 19, 2020CLOSE PRICE DECREASE: Sanara Medtech Inc (OTCBB: SMTI) on 02-19-2020 decreased close price > 10% from $16.95 to $13.50Read more...
Feb. 19, 2020CLOSE PRICE DECREASE: Valeritas Holdings Inc (NASDAQ: VLRX) on 02-19-2020 decreased close price > 10% from $0.35 to $0.28Read more...
Feb. 19, 2020CLOSE PRICE DECREASE: Guided Therapeutics Inc (OTCBB: GTHP) on 02-19-2020 decreased close price > 10% from $0.22 to $0.19Read more...